Mostrar el registro sencillo del ítem
dc.contributor.author | Citores González, Lucía | |
dc.contributor.author | Iglesias Álvarez, María del Rosario | |
dc.contributor.author | Ferreras Rodríguez, José Miguel | |
dc.date.accessioned | 2023-06-20T11:05:27Z | |
dc.date.available | 2023-06-20T11:05:27Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Toxins, 2021, Vol. 13, Nº. 2, 80 | es |
dc.identifier.issn | 2072-6651 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/59913 | |
dc.description | Producción Científica | es |
dc.description.abstract | Ribosome-inactivating proteins (RIPs) are rRNA N-glycosylases from plants (EC 3.2.2.22) that inactivate ribosomes thus inhibiting protein synthesis. The antiviral properties of RIPs have been investigated for more than four decades. However, interest in these proteins is rising due to the emergence of infectious diseases caused by new viruses and the difficulty in treating viral infections. On the other hand, there is a growing need to control crop diseases without resorting to the use of phytosanitary products which are very harmful to the environment and in this respect, RIPs have been shown as a promising tool that can be used to obtain transgenic plants resistant to viruses. The way in which RIPs exert their antiviral effect continues to be the subject of intense research and several mechanisms of action have been proposed. The purpose of this review is to examine the research studies that deal with this matter, placing special emphasis on the most recent findings. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Virus | es |
dc.subject | Virology | es |
dc.subject | Immunology | es |
dc.subject | Plantas - Biotecnología | es |
dc.subject | Plantas Transgénicas | es |
dc.subject | Virus diseases | es |
dc.subject | Proteins - Synthesis | es |
dc.subject | Proteínas | es |
dc.subject | Ribosomes - Structure | es |
dc.subject | Virus - Tratamiento | es |
dc.subject.classification | Ribosome-inactivating protein | es |
dc.subject.classification | Proteínas inactivadoras de ribosomas | es |
dc.subject.classification | Virus-resistant transgenic plant | es |
dc.subject.classification | Plantas transgénicas resistentes a virus | es |
dc.subject.classification | rRNA glycosylase | |
dc.subject.classification | ||
dc.title | Antiviral activity of ribosome-inactivating proteins | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © 2021 The authors | es |
dc.identifier.doi | 10.3390/toxins13020080 | es |
dc.relation.publisherversion | https://www.mdpi.com/2072-6651/13/2/80 | es |
dc.identifier.publicationfirstpage | 80 | es |
dc.identifier.publicationissue | 2 | es |
dc.identifier.publicationtitle | Toxins | es |
dc.identifier.publicationvolume | 13 | es |
dc.peerreviewed | SI | es |
dc.description.project | Junta de Castilla y León - (Grant VA033G19) | |
dc.identifier.essn | 2072-6651 | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
dc.subject.unesco | 2420 Virología | es |
dc.subject.unesco | 2412 Inmunología | es |
dc.subject.unesco | 2302 Bioquímica | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Atribución 4.0 Internacional